Anxiety Flashcards
Locus Coeruleus
overactive in eliciting fear response
Amygdala
overactive in anxiety/fear response
Anterior cingulate cortex
overactive in anxiety/fear response
hippocampus
consolidation of traumatic memory and contextual fear conditioning
Hypothalamus
integrates neuroendocrine and autonomic responses to a threat
Sympathetic nervous system
increase HR, vasoconstriction, dilation of bronchioles, decrease gastrointestinal motility
fight or flight
parasympathetic nervous system
decrease HR, no vascular changes, constriction of bronchioles, increase gastrointestinal motility
Rest and Digest
GAD general
One of the most common
Very prevalent
Linked with comorbidities
GAD risk factors
Women
economically disadvantaged
stressful event
chronic physical or mental illness
low affective support in childhood
genetics
GAD DSM-V definition
Excessive anxiety and worry, occurring most days for ≥ 6 months
Presence of ≥ 3 of (in adults, children just need 1)
-feeling on edge
-easily fatigued
-mind going blank
-irritability
-tense muscles
-sleep disturbance
GAD onset
mean 21 years
10-14 years, common in older adults
Treatment goal for GAD
Remission
Initial GAD treatment
Psychotherapy (CBT, IPT)
Medications (SSRI,SNRI)
Panic Disorder risk factors
Family history
Life stressor
Childhood abuse
Smoking
Anxious traits
Behavioral inhibition
Panic Attack definition
Distinct period of intense fear or discomfort when ≥ 4 of the following symptoms develop suddenly and peak within 10 minutes
increase HR
sweating
trembling
SOB
feeling of choking
chest pain
Nausea
Dizziness
numbness
chills/hot flash
Panic disorder definition
Recurrent, unexpected panic attacks with ≥ 1 of the attacks being followed by ≥ 1 month of one of the following
Constant concern about having another attack
Anxiety about attack
Change in behavior to avoid attack
if panic disorder treatment is urgent and no substance abuse
Short-term BZD (2-4 weeks) and SSRI or venlafaxine XR for 12 weeks
If panic disorder treatment is not urgent
SSRI or venlafaxine XR or 12 weeks
Social Anxiety Disorder risk factors
female
family history
behavioral inhibition
maternal stress
early childhood trauma
Social anxiety disorder DSM-V
Marked fear or anxiety about ≥ 1 social situation where the individual is exposed to possible scrutiny by others (e.g., eating, drinking, performing, conversing)
Social anxiety disorder clinical presentation
blushing
butterflies
diarrhea
sweating
tachycardia
trembling
Social anxiety disorder types
Generalized: fear and avoidance of a wide range of social situations
Performance specific: fear limited to speaking or public performance
Social anxiety disorder treatment
SSRI or venlafaxine XR for 12 weeks
BB for performance-related SAD
MOA: antagonist at beta-1 and beta-2 adrenoceptors
Treats physical symptoms
Propranolol
Caution -cardiovascular condition